The "well tempered" diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis. A report from combined meetings of The Society for Fetal Urology and members of The Pediatric Nuclear Medicine Council--The Society of Nuclear Medicine.
(41/217)
Perinatal hydronephrosis (HN) and hydroureteronephrosis (HUN) are recognized more frequently as the routine use of prenatal ultrasonography increases. The decision-making process for those instances of urinary tract dilatation that require surgical correction and those that do not is based in part on the findings of diuresis renography. The methodology for performing this test has differed among nuclear medicine practitioners and the surgical findings are occasionally discrepant from the diuretic renogram interpretation. Consequently, the Society of Fetal Urology (SFU) and the Pediatric Nuclear Medicine Council (PNMC) of the Society of Nuclear Medicine met to develop by consensus a more uniform methodology. A standard method has been agreed upon for the following facets of diuretic renography: patient preparation (hydration and bladder catheterization), diuresis renography technique (radiopharmaceutical used, patient position during examination, data acquisition parameters, diuretic pharmaceutical and dosage, time of injection and regions of interest to monitor diuretic effect), and data analysis (percent differential renal function, curve pattern analysis and methods of measuring diuretic response). Pooled diuresis renogram data are being collected for analysis for correlation with surgical results and clinical outcomes to determine the most appropriate information to be derived from the diuretic renogram in neonates with HN and HUN. (+info)
Reliability of captopril renography in patients under chronic therapy with angiotensin II (AT1) receptor antagonists.
(42/217)
Captopril renography is a reliable, widely used test for the functional diagnosis of renovascular hypertension. Well-recognized drawbacks of the procedure include reduced accuracy in patients with bilateral disease or renal impairment as well as the possible interference from concurrent antihypertensive medication (diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, calcium channel blockers). Currently, no data exist regarding the reliability of captopril renography in patients with renovascular hypertension evaluated while they are under chronic treatment with angiotensin II (AT1) receptor antagonists (Sartans). Moreover, the renographic response of the kidney with renal artery stenosis to prolonged therapy with angiotensin II receptor antagonists has not yet been evaluated. METHODS: We investigated the diagnostic effectiveness of (99m)Tc-mercaptoacetyltriglycine captopril renography performed after acute addition of 25 mg of captopril to the daily dose of AT1 receptor antagonist in 13 patients with unilateral renal artery stenosis and subsequent evidence of renovascular hypertension, based on short-term (3 mo) blood pressure outcome after revascularization. The renographic evaluation was first performed after ingestion of the daily therapy of angiotensin II receptor antagonist alone (Sartan renography) and was repeated within 7 d after the acute addition of 25 mg of captopril to chronic treatment with angiotensin II receptor antagonist (captopril-Sartan renography). A cohort of 13 patients with a final diagnosis of essential hypertension was chosen as the control subjects. RESULTS: Twelve of 13 patients were correctly detected by captopril-Sartan renography (92% sensitivity), and 3 subjects were also identified without the addition of captopril. Adding captopril to Sartan therapy resulted in a slight reduction in mean arterial blood pressure, while significant side effects were never observed. No false-positive results were found in the 13 patients with essential hypertension. CONCLUSION: We conclude that performing captopril renography with the acute addition of 25 mg of captopril to the chronic monotherapy with Sartans has the same diagnostic effectiveness as performing captopril renography alone. Interrupting the vasoactive action of angiotensin II alone on the efferent glomerular arteries, which can also be selectively achieved by chronic administration of angiotensin II receptor antagonists, does not fully explain the effectiveness of captopril renography in detecting renovascular hypertensive patients. (+info)
Volume expanded diuretic renography in the postnatal assessment of suspected uretero-pelvic junction obstruction.
(43/217)
Controversy surrounds the role of 99mTc-diethylenetriamine pentaacetic acid renography in suspected uretero-pelvic junction obstruction in early life. Accordingly, we retrospectively reviewed 18 patients (28 hydronephrotic kidneys) with a mean age of 2 mo (range: 1 wk-6 mo) who underwent a total of 36 scans using intravenous volume expansion (10 ml/kg) and furosemide diuresis (1 mg/kg). Initial scans were classified as obstructed, not obstructed or indeterminate using differential renal function, furosemide washout T 1/2 and visual assessment of tracer clearance. Those initially classified as obstructed (n = 8) have been surgically confirmed. In the indeterminate (n = 6) and nonobstructed (n = 14) groups, three and two kidneys, respectively, developed obstruction on progress scans. Mean follow-up in the nonsurgical patients was approximately 9 mo (range: 4-17 mo). A total of 13 kidneys had developed obstruction by renographic criteria, and to date 12 have surgical confirmation. Our data indicate that: (1) scans classified as obstructed correlate well with surgery; (2) an initial classification of indeterminate or nonobstructed does not exclude later development of obstruction; and (3) serial scans correctly stratify children with possible uretero-pelvic junction obstruction. (+info)
Administered activity optimization in 99mTc-MAG3 renography for adults.
(44/217)
OBJECTIVE: The objective of this work was to determine the minimum administered activity of (99m)Tc-mercaptoacetyltriglycine (MAG3) needed both to estimate effective renal plasma flow (ERPF) with adequate precision and to obtain good image quality. METHODS: Three groups of 10 patients each were injected with 45, 71, or 132 MBq of MAG3. Renograms and perfusion and clearance images were obtained. The age, sex, and weight of the patients; the labeling yield; the mean count and counting rate 2 min after injection; the kidney-to-background and cortex-to-background ratios; the uptake time from the renograms; the percentage of the injected activity 2 min after injection in the left and right kidneys (A2(LK) and A2(RK), respectively); and the ERPF for both kidneys were obtained and analyzed. Discriminant analysis of image quality was used to select the variables that most affected image quality. The selected variables were studied among activity groups to optimize the amount of activity administered in these studies. RESULTS: Precision in ERPF assessment did not significantly differ among administered activity levels (P = 0.824). The SDs of the ERPF were +/-1.5 for 132 MBq, +/-1.7 for 71 MBq, and +/-2.0 for 45 MBq. The labeling yield, the ratios of counts in the left and right kidneys to the background and in the left and right cortices to the background, and A2(LK) and A2(RK) were the only variables that provided a significant discriminant function for image quality. The only variable that significantly differed with the variation in administered activity was the ratio of counts in the right kidney to the background (P = 0.026), most likely because of the labeling yield. CONCLUSION: A 45-MBq activity is sufficient to guarantee good image quality and adequate precision in ERPF determination from the time-activity curve, provided the labeling yield is kept high. (+info)
Quantitative analysis of 99mTc-DMSA during acute pyelonephritis for prediction of long-term renal scarring.
(45/217)
This study was performed to evaluate a quantitative method based on (99m)Tc-DMSA renal planar scintigraphy performed during acute pyelonephritis (APN) to detect kidneys at risk of scarring. METHODS: A total of 43 children (5.8 +/- 3.6 y old [mean +/- SD]) were examined by (99m)Tc-DMSA scintigraphy during (DMSA 1) and 8 +/- 2 mo after (DMSA 2) APN. Two levels of interpretation were performed independently: first, a semiquantitative analysis to classify the kidneys by considering the evolution between DMSA 1 and DMSA 2 (i.e., to determine which kidneys had developed scarring), and second, an automatic quantitative analysis of DMSA 1 to define and to evaluate a predictive index for kidney evolution from DMSA 1 to DMAS 2. The method consisted of determining an automatic threshold for the kidney and then calculating ratios of the count density in a given isocount n% (region of interest containing all the pixels with a value > or = n% of the value of the pixel with the maximal activity value) to the count density in a 20% isocount (C(n%)) and the number of pixels in a given isocount to the number of pixels in a 20% isocount (S(n%)). RESULTS: All kidneys normal at DMSA 1 remained normal at DMSA 2. For the automatic index, the C(70%) ratio was considered the best index for the prediction of scarring. When this C(70%) ratio was used, a cutoff value of 0.45 was able to predict scarring with a sensitivity of 0.83, a specificity of 0.78, a positive predictive value of 0.85, and a negative predictive value of 0.77. CONCLUSION: A cutoff value of 0.45 for the C(70%) ratio calculated for (99m)Tc-DMSA scintigraphy performed during APN may be useful for detecting kidneys at risk of scarring. (+info)
New automated physical phantom for renography.
(46/217)
Physical phantoms have been used to test the diagnostic proficiency of nuclear medicine professionals and the accuracy of their equipment in external quality assurance surveys. No dynamic renal phantoms are commercially available. A new renal phantom, presented in this paper, was constructed and patented in the United States. METHODS: The organs to be simulated by the phantom were in the form of containers filled with radioactive solution, and the device further comprised movable steel and lead plates between the containers and the gamma-camera. The detectable radiation was regulated in accordance with automated computer-controlled step motors to move the attenuators to simulate a given patient situation. The reproducibility of the phantom measurements was defined as a coefficient of variation. Four different kidney-function simulations were repeated 3 times, and 6 parameters were compared. RESULTS: The average root mean square deviation of the coefficient of variation was 6.7% for the perfusion integral, 1.3% for time to reach the maximum activity, 19.7% for mean transit time, 3.3% for function (Patlak [%]), 1.0% for outflow index (%), and 6.5% for time to reach the half-activity from maximum. CONCLUSION: With this phantom, the true values of most parameters measured are well known; it closely approaches true extraction, washout, and attenuation properties and curves, and the images produced are similar to those of patient studies. Compared with the first manual version, this new automated phantom is easy to use. Any desired clinical situation can be programmed. It is a promising tool for quality assurance and calibration of renography. (+info)
Assessment of rapid changes in renal blood flow with (191m)Ir, an ultra-short-lived radionuclide.
(47/217)
We investigated the feasibility of using (191m)Ir (half-life, 5 s) to measure rapid dynamic alterations in differential renal blood flow. METHODS: A nonobstructive constant renal pelvic pressure model was used. The renal pelves of 6 New Zealand White rabbits were drained by use of bilateral catheters, and increased hydrostatic pressure was achieved by raising 1 catheter to 16, 25, 30, or 35 cm above the level of the renal pelvis. The contralateral kidney served as the control. (191m)Ir first-pass angiograms were obtained at baseline, after the induction of elevated pressure in the renal pelvis, and after the pressure was returned to normal. A minimum of 3 sequential angiograms were obtained at each point. RESULTS: The differential blood flow values (mean +/- SD) were 47.5% +/- 7.3% at baseline, decreased to 42.3% +/- 2.6% when the renal pelvic pressure was elevated (P = 0.001), and returned to 51.1% +/- 4.0% after the pressure was returned to normal (P = 0.0017). There was no significant difference between baseline and postcompression values (P = 0.4807). CONCLUSION: It is possible to use (191m)Ir first-pass angiography to evaluate rapid dynamic changes in differential renal blood flow in an experimental animal model. (+info)
Elimination of the influence of total renal function on renal output efficiency and normalized residual activity.
(48/217)
One of the potential limitations in the usefulness of both renal output efficiency (ROE) and normalized residual activity (NORA) is their residual dependence on total renal function. The purpose of this study was to present and examine a new quantitative method whereby the effects of this dependence may be removed. METHODS: The analytic method involves the determination of a retention function using an unconstrained matrix algorithm deconvolution technique followed by reconvolution with a chosen standard input function to yield a new secondary renal activity time (A/T) curve from which normalized values of ROE and NORA, denoted as N_ROE and N_NORA, respectively, can then be obtained using conventional definitions. The method has been applied in a series of 50 patient studies, which had been acquired using (99m)Tc-mercaptoacetyltriglycine (99(m)Tc-MAG3) and a standard F+18 furosemide protocol, with values of the ratio of plasma clearance to plasma volume (C/V) in the range 0.013-0.242 min(-1). RESULTS: Pre- and postnormalization values of NORA, calculated at 30 min after injection, showed a significant difference in mean values (paired t test; P < 0.001), with a maximum observed difference, DeltaNORA(30), of -4.82 (-482%) and with a SD on the paired differences, DeltaNORA(30), of 0.56 (56%) or 0.63 (63%) if background subtraction on the input function (BSIF) had been performed. In contrast, corresponding values of ROE showed a nonsignificant difference in means (P > 0.05) and a SD on the paired differences, DeltaROE(30), of 3.7% or 3.2% with and without BSIF, respectively. The normalized parameters N_ROE and N_NORA were found to be strongly linearly correlated (r = -0.99; P < 0.001), in agreement with theoretical predictions. CONCLUSION: These results suggest that renal function affects NORA significantly more than ROE. The effects can be corrected by our normalization technique, resulting in equivalent values of normalized ROE and normalized NORA. (+info)